Population Health Management Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) & Region - Global Forecast to 2027
Market Growth Outlook Summary
The global population health management market growth forecasted to transform from $27.8 billion in 2022 to $53.3 billion by 2027, driven by a CAGR of 13.9%. This research study analyzes industry trends, pricing, patents, stakeholder dynamics, and consumer behavior. Each country's market overview has been updated, including country-specific market size and share data. Key growth drivers include regulatory compliance, cost reduction, and the rising demand for patient-centric care. However, challenges such as a shortage of skilled IT professionals and security concerns are impacting market expansion.
To learn more about the study's assumptions, request a free sample report.
Population Health Management Market Dynamics
Driver: Aging Population and Chronic Disease Burden
The increasing elderly population and the associated rise in chronic diseases are placing immense pressure on healthcare systems. Key statistics include:
- People aged 65 or older are expected to rise from 524 million in 2010 to nearly 1.5 billion by 2050, predominantly in developing countries (source: WHO).
- In the US, the population over 65 is projected to double from 2005 to 2030 (source: National Institute on Aging).
- Approximately 92% of older adults have at least one chronic disease, with heart disease, cancer, stroke, and diabetes accounting for two-thirds of annual deaths in the US (National Council on Aging).
With a growing elderly demographic requiring healthcare services, costs are set to rise. Population health management solutions, including Electronic Health Records (EHR), are increasingly adopted to alleviate the burden on healthcare systems worldwide.
Opportunity: Emphasis on Value-Based Medicine
Value-based medicine focuses on capturing and utilizing outcomes-oriented data. Business intelligence tools help healthcare organizations analyze data to assess costs versus benefits, enhancing transparency and improving decision-making. The transition from fee-for-service to value-based reimbursement models is spurring growth in the population health management sector, driven by the need for quality care and competitive advantage.
Restraint: Data Breach Concerns
Data breaches, particularly medical identity theft, pose significant challenges in healthcare, often due to inadequate internal controls and outdated policies. Cloud-based population health management solutions face scrutiny over security, as breaches have increased—616 healthcare data breaches were reported in the US in 2020, a 66% increase since 2018. The need for secure communication platforms remains a major hurdle for IT vendors in healthcare.
Challenge: Interoperability Issues
A significant barrier to effective population health management is the lack of interoperability across healthcare systems. Engaging patients with meaningful health information is crucial, yet many struggle to access their health records. Poor interoperability requires hospitals to manage numerous complex data interfaces, complicating care coordination and increasing operational costs.
Software: Fastest Growing Segment
The software segment of the population health management market is expected to experience the highest growth due to its ability to reduce readmissions, enhance patient engagement, and offer customization flexibility.
Healthcare Providers: Leading End User Segment
Healthcare providers represent the largest end user segment in the population health management market, driven by a growing patient pool and the need for efficient patient data management.
North America: Market Leader
North America holds the largest share of the population health management market, fueled by stringent regulations, government support for healthcare infrastructure, and the presence of major market players.
For more details about the study's assumptions, download the PDF brochure.
The population health management market is led by established players such as Cerner Corporation, Epic Systems, Koninklijke Philips, and Health Catalyst, among others.
Scope of the Population Health Management Industry
| Report Metric | Details |
| Market Revenue in 2022 | $27.8 billion |
| Projected Revenue by 2027 | $53.3 billion |
| Revenue Rate | CAGR of 13.9% |
| Market Driver | Aging population and chronic disease burden |
| Market Opportunity | Increasing focus on value-based medicine |
The study categorizes the global population health management market to forecast revenue and analyze trends across various submarkets:
By Product & Service
- Software
- Services
By Mode of Delivery
- On-premise
- Cloud-based
By End User
- Healthcare Providers
- Healthcare Payers
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments in Population Health Management
- Cerner Corporation and Change Healthcare partnered in January 2021 to enhance PHM capabilities.
- Humana acquired Genoa Healthcare in March 2021 for population health technology.
- Optum and the Advisory Board Company merged in April 2021 to strengthen PHM analytics.
- CVS Health announced the acquisition of Aetna in May 2021, integrating PHM components.
- UnitedHealth Group acquired Change Healthcare in June 2021 to bolster PHM offerings.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global population health management market?
The global population health management market boasts a total revenue value of $53.3 billion by 2027.
What is the estimated growth rate (CAGR) of the global population health management market?
The global population health management market has an estimated compound annual growth rate (CAGR) of 13.9% and a revenue size in the region of $27.8 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 POPULATION HEALTH MANAGEMENT INDUSTRY DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
FIGURE 2 REGIONAL SEGMENTS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 40)
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GLOBAL MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 GLOBAL POPULATION HEALTH MANAGEMENT INDUSTRY: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 44)
4.1 POPULATION HEALTH MANAGEMENT INDUSTRY OVERVIEW
FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: MARKET, BY END USER AND COUNTRY (2021)
FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: GLOBAL MARKET (2022−2027)
FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
4.5 GLOBAL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 48)
5.1 INTRODUCTION
5.2 POPULATION HEALTH MANAGEMENT INDUSTRY DYNAMICS
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
FIGURE 20 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Government mandates and support for healthcare IT solutions
5.2.1.2 Need to curtail escalating healthcare costs
FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)
5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
5.2.2 RESTRAINTS
5.2.2.1 High investments in infrastructure to set up robust PHM program
5.2.2.2 Rising data breach concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Growing importance of emerging markets in healthcare sector
5.2.3.2 Rising focus on personalized medicine
5.2.3.3 Increasing focus on value-based medicine
5.2.4 CHALLENGES
5.2.4.1 Lack of data management capabilities and skilled analysts
5.2.4.2 Interoperability issues
6 INDUSTRY INSIGHTS (Page No. - 57)
6.1 POPULATION HEALTH MANAGEMENT INDUSTRY TRENDS
6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
FIGURE 22 VALUE-BASED CARE WORKFLOW
6.1.4 CLOUD-BASED IT SOLUTIONS
6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
6.2 ECOSYSTEM ANALYSIS
FIGURE 23 GLOBAL MARKET: ECOSYSTEM ANALYSIS
6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
6.3.1 INTRODUCTION
FIGURE 24 ACOS: REIMBURSEMENT MODEL
6.3.2 US: EVOLUTION OF ACOS
FIGURE 25 EVOLUTION OF ACO MODELS
6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
6.4 HCIT EXPENDITURE ANALYSIS
6.4.1 NORTH AMERICA
TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
6.4.2 EUROPE
6.4.3 ASIA PACIFIC
TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
6.5 REGULATORY ANALYSIS
6.5.1 NORTH AMERICA
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
6.6 PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN GLOBAL MARKET
TABLE 7 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7 PATENT ANALYSIS
FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022)
FIGURE 29 PATENT ANALYSIS: GLOBAL MARKET (JANUARY 2017–SEPTEMBER 2022)
6.8 ADJACENT MARKET ANALYSIS
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
6.9 CASE STUDY
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
6.10.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
6.11 KEY CONFERENCES AND EVENTS (2022-2023)
6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 34 REVENUE SHIFT IN GLOBAL MARKET
6.13 PRICING ANALYSIS
6.13.1 INITIAL FEES
TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
6.13.2 ANNUAL MAINTENANCE FEES
TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
6.14 TECHNOLOGY ANALYSIS
6.14.1 INTEGRATION OF AI AND ML
6.14.2 DATA ANALYTICS
7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT (Page No. - 80)
7.1 INTRODUCTION
TABLE 12 GLOBAL POPULATION HEALTH MANAGEMENT INDUSTRY, BY COMPONENT, 2020–2027 (USD MILLION)
7.2 SOFTWARE
7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SERVICES
7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY (Page No. - 88)
8.1 INTRODUCTION
TABLE 17 GLOBAL POPULATION HEALTH MANAGEMENT INDUSTRY, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
8.2 ON-PREMISE MODE OF DELIVERY
8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
TABLE 19 GLOBAL MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLOUD-BASED MODE OF DELIVERY
8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
TABLE 21 GLOBAL MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER (Page No. - 93)
9.1 INTRODUCTION
TABLE 22 GLOBAL POPULATION HEALTH MANAGEMENT INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
9.2 HEALTHCARE PROVIDERS
9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
TABLE 23 GLOBAL MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 HEALTHCARE PAYERS
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
TABLE 24 GLOBAL MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 OTHER END USERS
TABLE 25 GLOBAL MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION (Page No. - 99)
10.1 INTRODUCTION
TABLE 26 GLOBAL MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 31 US: MACROECONOMIC INDICATORS
TABLE 32 US: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 33 US: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 34 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital health initiatives to boost market
TABLE 35 CANADA: MACROECONOMIC INDICATORS
TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT INDUSTRY, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 37 CANADA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 38 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 42 EUROPE: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 43 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European population health management industry
TABLE 44 GERMANY: MACROECONOMIC INDICATORS
TABLE 45 GERMANY: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 46 GERMANY: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 47 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
TABLE 48 UK: MACROECONOMIC INDICATORS
TABLE 49 UK: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 50 UK: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 51 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
TABLE 52 FRANCE: MACROECONOMIC INDICATORS
TABLE 53 FRANCE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 54 FRANCE: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Government initiatives to support market
TABLE 56 ITALY: MACROECONOMIC INDICATORS
TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 58 ITALY: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 59 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
TABLE 60 SPAIN: MACROECONOMIC INDICATORS
TABLE 61 SPAIN: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 63 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT INDUSTRY, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 67 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
TABLE 71 JAPAN: MACROECONOMIC INDICATORS
TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 73 JAPAN: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strong government support to propel market
TABLE 75 CHINA: MACROECONOMIC INDICATORS
TABLE 76 CHINA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 77 CHINA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 78 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
TABLE 79 INDIA: MACROECONOMIC INDICATORS
TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 81 INDIA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 82 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 83 REST OF ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT INDUSTRY, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 88 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
TABLE 89 MIDDLE EAST & AFRICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 138)
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
11.4 REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 40 GLOBAL MARKET: GEOGRAPHIC REVENUE MIX
11.6 COMPANY EVALUATION QUADRANT
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
11.8 KEY PLAYERS ANALYSIS
TABLE 92 GLOBAL MARKET ANALYSIS, BY VENDOR TYPE
11.9 COMPETITIVE SITUATIONS AND TRENDS
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES (Page No. - 151)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 CERNER CORPORATION
TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
12.1.3 IBM CORPORATION
TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
12.1.4 EPIC SYSTEMS CORPORATION
TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
12.1.5 KONINKLIJKE PHILIPS
TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.6 I2I POPULATION HEALTH
TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
12.1.7 HEALTH CATALYST
TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
TABLE 100 OPTUM, INC: COMPANY OVERVIEW
FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
12.1.10 ECLINICALWORKS
TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
12.1.11 HEALTHEC, LLC
TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
12.1.12 MEDECISION
TABLE 104 MEDECISION: COMPANY OVERVIEW
12.1.13 ARCADIA
TABLE 105 ARCADIA: COMPANY OVERVIEW
12.1.14 ATHENAHEALTH
TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
TABLE 107 COTIVITI: COMPANY OVERVIEW
12.1.16 NEXTGEN HEALTHCARE, INC.
TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 CONIFER HEALTH SOLUTIONS
12.2.2 SPH ANALYTICS
12.2.3 LIGHTBEAM HEALTH SOLUTIONS
12.2.4 INNOVACCER
12.2.5 LUMERIS
12.2.6 ZEOMEGA
12.2.7 HGS HEALTHCARE, LLC
12.2.8 PERSIVIA
12.2.9 COLOR HEALTH, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 199)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research study involved the extensive use of both primary and secondary sources. Various factors affecting the industry were studied to identify segmentation types; industry trends; key players; the competitive landscape of the market; and key market dynamics, such as drivers, restraints, opportunities, challenges, and key player strategies.
Secondary Research
This research study involved secondary sources; directories; databases such as Bloomberg Business and Factiva; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the population health management market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, marketing managers, regional/area sales managers, product managers, distributors, business development managers, technology & innovation directors of population health management software solutions providers, KOLs, and suppliers & distributors. Primary sources from the demand side include industry experts such as directors of hospitals, ambulatory surgical centers, healthcare payers, and healthcare providers.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the population health management market was arrived at after data triangulation from five different approaches, as mentioned below. After each approach, the weighted average of approaches was taken based on the level of assumptions used.
Data Triangulation
The individual share of each segment was arrived at by assigning weightages based on their utilization rate. The regional splits of the market and its subsegments are based on the adoption or utilization rates of the given solutions in the respective regions or countries. For countries with the limited availability of reliable and recent data, the analogy/benchmarking-based market estimation and forecast technique was used.
Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Objectives of the Study
- To define, describe, and forecast the size of the population health management market on the basis of component, mode of delivery, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically analyze the market structure and profile the key players in the global market and comprehensively analyze their core competencies2
- To track and analyze company developments such as agreements, collaborations, partnerships, acquisitions, expansions, and solution launches & enhancements in the population health management market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific market into Australia, South Korea, New Zealand, Hong Kong, Singapore, and other countries
- Further breakdown of the Rest of Europe market into Russia, Switzerland, the Netherlands, Nordic countries, and other countries
Generating Response ...
Growth opportunities and latent adjacency in Population Health Management Market
Some of the disruptions in population health management market 2030 includes:
What are the disruptions happening in population health management market in 2030?
Population health management market in 2030 will grow at a considerable CAGR.
Some of the possible predictions of population health management market in 2030 are:what are the predictions of population health management market 2030 ?